Drug: TENOFOVIR DISOPROXIL FUMARATE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
73265815 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160909 | US | |
73285784 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160705 | US | |
117931097 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | VIIV | -0.75 YR | F | 3 KG | 20160728 | US |
125223101 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | JANSSEN | 0.00 | 0 | 20160701 | US | |
126816341 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | GILEAD | 21.00 DY | F | 3 KG | 20160824 | ES |
126894951 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | ROCHE | 0.00 | 0 | 20160826 | US | |
127028581 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | VIIV | 0.00 | F | 0 | 20160831 | MZ |
127029621 | TENOFOVIR DISOPROXIL FUMARATE. | Foetal exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160831 | MZ |
Total Records: 8 Number of Pages: 1